✦ LIBER ✦

ArePALB2mutations associated with increased risk of male breast cancer?

✍ Scribed by A. Sauty de Chalon; Z. Teo; D. J. Park; F. A. Odefrey; kConFab; J. L. Hopper; M. C. Southey

Publisher: Springer US
Year: 2009
Tongue: English
Weight: 155 KB
Volume: 121
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-009-0673-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Increased cancer risk associated with br

Increased cancer risk associated with breast tenderness during HRT

✍ Carrie Printz 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 874 KB

Increased risk of severe depression in m

Increased risk of severe depression in male partners of women with breast cancer

✍ Naoki Nakaya; Kumi Saito-Nakaya; Pernille Envold Bidstrup; Susanne Oksbjerg Dalt 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 2 views

CHEK2 variant I157T may be associated wi

CHEK2 variant I157T may be associated with increased breast cancer risk

✍ Outi Kilpivaara; Pia Vahteristo; Jacob Falck; Kirsi Syrjäkoski; Hannaleena Eerol 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 173 KB

## Abstract Cell cycle checkpoint kinase 2 (CHEK2) is a transducer of cellular responses to DNA damage. The __CHEK2__ 1100delC has previously been shown to be a low‐penetrance breast cancer susceptibility allele. We have evaluated the role of another __CHEK2__ variant, I157T in the FHA domain of th

ACYP19(aromatase) polymorphism is associ

ACYP19(aromatase) polymorphism is associated with increased premenopausal breast cancer risk

✍ Kathryn E. Talbott; Marilie D. Gammon; Muhammad G. Kibriya; Yu Chen; Susan L. Te 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 180 KB

c-MYC Asn11Ser is associated with increa

c-MYC Asn11Ser is associated with increased risk for familial breast cancer

✍ Michael Wirtenberger; Kari Hemminki; Asta Försti; Rüdiger Klaes; Rita K. Schmutz 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 98 KB

c-MYC is a multifaceted protein that regulates cell proliferation, differentiation and apoptosis. Its crucial role in diverse cancers has been demonstrated in several studies. Here, we analysed the influence of the rare c-MYC Asn11Ser polymorphism on familial breast cancer risk by performing a case-

LRRK2 G2019S mutations are associated wi

LRRK2 G2019S mutations are associated with an increased cancer risk in Parkinson disease

✍ Rachel Saunders-Pullman; Matthew J. Barrett; Kaili M. Stanley; Marta San Luciano 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

## Abstract Leucine rich repeat kinase (__LRRK2__) G2019S mutations are presumed to cause PD through a toxic gain of function of the protein kinase. Small molecule kinase inhibitors have been developed for the treatment of certain cancers, and some antioncogenic agents such as sunitinib, may nonspe